PET scan

Biomarker

1 paper

  • Human trial1

Latest

Nov 2025: 0Dec 2025: 74Jan 2026: 20Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 2Sep 2026: 4Oct 2026: 3103 in 12 months
NPJ Dementia

Neighbourhood deprivation linked to brain amyloid buildup

In an observational study of 1,110 people, living in more deprived areas was associated with lower cognitive scores and more amyloid build-up in unimpaired brains.In an observational study of 1,110 people, living in more deprived areas was associated with lower cognitive scores and more amyloid build-up in unimpaired brains.

Cross-sectional study of 1,110 peoplePopulations
medRxiv

Lifestyle trial found similar Alzheimer’s blood marker changes

A two-year randomised trial in 1,260 older adults at risk of dementia found no clear evidence that starting blood markers altered cognitive benefits.A two-year randomised trial in 1,260 older adults at risk of dementia found no clear evidence that starting blood markers altered cognitive benefits.

Preprint: randomised trial in 1,260 peopleAlzheimer's disease
Sleep Medicine

Dopamine loss in sleep disorder predicts Parkinson conversion

In PET scans of 77 patients with isolated REM sleep behavior disorder, quantitative dopamine markers showed intermediate loss and predicted phenoconversion toward…In PET scans of 77 patients with isolated REM sleep behavior disorder, quantitative dopamine markers showed intermediate loss and predicted phenoconversion toward Parkinson's disease.

Cohort study of 194 peopleParkinson's disease
medRxiv

Tool converts plasma pTau217 values across testing platforms

Assays predicted amyloid-beta positivity with AUCs of 0.929 to 0.952, while simulated pTau217 screening cut amyloid PET scans by over 60%.Assays predicted amyloid-beta positivity with AUCs of 0.929 to 0.952, while simulated pTau217 screening cut amyloid PET scans by over 60%.

Preprint: cohort study in peoplepTau217